Applied Therapeutics, Inc.
Applied Therapeutics, Inc. (APLT) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · APLT · as of Mar 31, 2024
Ownership Breakdown
100
Institutional Holders
▲ 10 vs Q4
$638.61M
Total Inst. Value
▲ $432.90M vs Q4
144.30M
Shares Outstanding
freeFloat 83.04%
93.97M
13F Shares Held
▲ 32.55M vs Q4
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
APLT largest shareholders · institutional ownership
Q1 2024 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
FRANKLIN RESOURCES INC pharmaceutical preparations | 10.56M | 8.43% | 8.43% | $71.84B | May 13, 2024 | ▲ 3.55M |
VR ADVISER, LLC pharmaceutical preparations | 9.07M | 7.24% | 7.24% | $61.71B | May 15, 2024 | ▲ 2.83M |
PERCEPTIVE ADVISORS LLC pharmaceutical preparations | 8.01M | 6.39% | 6.39% | $54.43B | Aug 6, 2024 | ▲ 3.92M |
JANUS HENDERSON GROUP PLC pharmaceutical preparations | 6.41M | 5.12% | 5.12% | $43.56B | May 15, 2024 | ▲ 4.27M |
PROPEL BIO MANAGEMENT, LLC pharmaceutical preparations | 6.11M | 4.88% | 4.88% | $41.56B | May 13, 2024 | ▲ 736.9K |
KNOLL CAPITAL MANAGEMENT, LLC pharmaceutical preparations | 5.57M | 4.45% | 4.45% | $37.91B | May 15, 2024 | ▲ 100.0K |
VESTAL POINT CAPITAL, LP pharmaceutical preparations | 5.11M | 4.08% | 4.08% | $34.75B | May 14, 2024 | ▲ 955.0K |
ALYESKA INVESTMENT GROUP, L.P. pharmaceutical preparations | 4.00M | 3.19% | 3.19% | $27.20B | May 15, 2024 | ▼ 3.50M |
MORGAN STANLEY pharmaceutical preparations | 3.19M | 2.55% | 2.55% | $21.72B | Oct 17, 2024 | ▲ 3.14M |
VANGUARD GROUP INC pharmaceutical preparations | 3.01M | 2.40% | 2.40% | $20.47B | May 10, 2024 | ▼ 220.2K |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q1 2024 vs prior quarter
Q1 2024
29
Increased
+30.23M shares11
New Positions
first time holders9
Decreased
−5.91M shares0
Sold Out
fully exitedNet shares change (top 50)
+24.31M
+30.23M / −5.91M
Net new holders
+31
11 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
APLT insider trading · insider activity
Source: SEC Form 4
1
Buy transactions
25
Sell transactions
0.04
Buy/Sell ratio
$7M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Kanter Stacy J. director | Feb 3, 2026 | D-Return | 22,500 | $0.09 | $2.0K | 42.5K | Form 4 ↗ |
Kanter Stacy J. director | Feb 3, 2026 | D-Return | 200,000 | $0.40 | $79.0K | 0 | Form 4 ↗ |
Kanter Stacy J. director | Feb 3, 2026 | U-Tender | 42,500 | $0.09 | $3.7K | 0 | Form 4 ↗ |
Kanter Stacy J. director | Feb 3, 2026 | D-Return | 16,500 | $1.05 | $17.3K | 0 | Form 4 ↗ |
Hooks Corwin Dale Chief Commercial Officer | Dec 19, 2025 | Award | 312,500 | — | — | 868.3K | Form 4 ↗ |
Hooks Corwin Dale Chief Commercial Officer | Feb 3, 2026 | D-Return | 862,500 | $0.09 | $75.9K | 5.8K | Form 4 ↗ |
Hooks Corwin Dale Chief Commercial Officer | Feb 3, 2026 | U-Tender | 5,753 | — | — | 0 | Form 4 ↗ |
Chinoporos Constantine See Remarks | Dec 19, 2025 | Award | 437,500 | — | — | 1.06M | Form 4 ↗ |
Chinoporos Constantine See Remarks | Feb 3, 2026 | D-Return | 1,000,000 | $0.09 | $88.0K | 57.1K | Form 4 ↗ |
Chinoporos Constantine See Remarks | Feb 3, 2026 | U-Tender | 57,111 | — | — | 0 | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Applied Therapeutics, Inc. (APLT) is primarily owned by institutional investors, who hold approximately 65.1% of total shares outstanding. Company insiders own approximately 16.96%, while retail and public investors account for the remaining 17.93%.
The largest institutional shareholder of Applied Therapeutics, Inc. is FRANKLIN RESOURCES INC, holding approximately 10.56 million shares — equal to 8.43% of outstanding shares — as of March 31, 2024.
A total of 100 institutional investors currently hold APLT stock, with a combined institutional value of approximately $638,614,645 as of the most recent 13F filing period.
Frequently asked questions
APLT ownershipApplied Therapeutics, Inc. (APLT) is primarily owned by institutional investors, who hold approximately 65.1% of shares. The largest shareholder is FRANKLIN RESOURCES INC with a 8.43% stake. Company insiders hold 16.96%. Data sourced from SEC Form 13F as of March 31, 2024.